Stay updated on APL-2 in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page’s error changes from a 403 Forbidden response to “TypeError: Failed to fetch,” and the NIH transition notice is no longer shown.
    Difference
    1%
    Check dated 2026-11-07T13:11:37.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:49:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with both terms appearing during the transition.
    Difference
    1%
    Check dated 2026-10-24T17:11:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T17:00:14.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T17:20:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating the study record is temporarily inaccessible. The standard page chrome (header/footer) remains visible while the main content is unavailable.
    Difference
    17%
    Check dated 2026-09-19T20:29:23.000Z thumbnail image

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.